华法林相关出血的临床预测因素:一个病例控制研究
Shahanaze Javath Hussain1, Surendran Deepanjali2, Hemachandren Munuswamy3
1Senior Resident, Department of Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
Tropical doctor
|October 10, 2024
概括
华法林出血的危险因素在不同的人群中不同. 减少食物摄入量,年龄较大和先前出血预测了与华法林相关的出血事件,需要更密切的监测.
科学领域:
- 内部医学 内部医学
- 药理学 药理学是指药理学的学科.
- 临床研究 临床研究
背景情况:
- 在资源有限的环境中,华法林对于抗凝剂仍然至关重要.
- 由于华法林过量服用而导致的出血是一个重大的临床问题.
- 华法林诱导出血的危险因素可能因患者人口统计学而异.
研究的目的:
- 为了确定成年患者出血的独立预测因素,处方华法林.
- 评估HAS-BLED得分在预测华法林相关出血事件中的有用性.
主要方法:
- 采用了一种病例控制研究设计.
- 病例是服用华法林的成年人出现出血;对照组是服用华法林但没有出血.
- 对所有参与者计算HAS-BLED分数.
主要成果:
- 减少食物摄入量与出血事件密切相关.
- 出血的独立预测因素包括年龄,高华法林剂量,最近的疾病和以前的出血史.
- 在这个队列中,HAS-BLED评分不能独立预测出血.
结论:
- 减少食物摄入量和最近的疾病等特定因素需要注意华法林的安全性.
- 强化监测国际规范化比率 (INR) 建议在急性疾病和患者的食物摄入量下降.
- 临床实践应根据确定的患者特异性风险因素调整华法林管理.
相关概念视频
Disorders of Hemostasis
737
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
737
Venous Thrombosis III: Interprofessional Care
3
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
3
Venous Thrombosis IV: Nursing Management
3
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
3
Anticoagulant Drugs: Low-Molecular-Weight Heparins
633
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
633
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
123
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
123
Extrinsic and Intrinsic Pathways of Hemostasis
6.1K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
6.1K


